After the program the proportion of GPs who appropriately ‘agreed’ or ‘strongly agreed’ that fluoxetine should be the first-line choice of medicine when an antidepressant is required for adolescents increased by 14%.
GPs practising for 10 years or less were more likely to provide the desired response for this statement than those practising for a longer period (p ≤ 0.001).
Figure 1: GPs’ level of agreement with the use of fluoxetine first line for adolescents.
When selecting an antidepressant, the program encouraged GPs to consider the efficacy and potential adverse effects of antidepressants.
After the program the proportion of GPs who appropriately disagreed or strongly disagreed that ‘Venlafaxine is an appropriate first-line antidepressant, based on high risk levels of suicidal ideation’ increased by about 8%.
Comparing GPs who participated in the program with those who did not participate, the improvement was seen only for participant GPs (30% to 38%, p = 0.058). It should be highlighted that the role for venlafaxine in this area is complex, so it is unsurprising that almost half the GPs had a neutral response to this statement.
Figure 2: GPs’ level of agreement with the use of venlafaxine.